title: Elderly CML patients' treatment: considering not only physician's judgment but also co-morbidity indexes.
authors.affiliation: Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain. Electronic address: ferminsg@usal.es.
authors.forename: Fermín
authors.initials: F
authors.lastname: Sánchez-Guijo
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate
keywords: CML; Chronic myeloid leukemia; Co-morbidities; Elderly; Tyrosine kinase inhibitors